NeuMoDx Molecular Systems

REVOLUTIONARY MOLECULAR DIAGNOSTIC SOLUTION

Our patented, “sample to result” platform offers market-leading ease of use,true continuous random-access and rapid turnaround time while achieveing optimal operational and clinical performance for our customers and their patients.

SAMPLE TO RESULT

The NeuMoDx™ Molecular, a QIAGEN company are a family of scalable platforms that fully integrate the entire molecular diagnostic process from “sample to result”. The NeuMoDx™ 288 and the NeuMoDx™ 96 Molecular Systems are fully automated, continuous random-access analyzers that utilize our proprietary NeuDry™ reagent technology, which integrates magnetic particle affinity capture and real time Polymerase Chain Reaction (PCR) chemistry in a multi-sample microfluidic cartridge. This technology, combined with a platform, uniquely incorporates robotics and microfluidics that result in higher throughput, improved performance and increased efficiency by eliminating the waste associated with technologies that required reconstitution of lyophilized reagents.

NeuMoDx™ has recently received FDA 510(k) clearance for its NeuMoDx™ GBS Assay for the detection of Group B Streptococcus (GBS) DNA in antepartum pregnant women and will continue development of tests to detect and monitor sexually transmitted and infectious diseases. Additionally, NeuMoDx™ offers a broad range of general purpose reagents and consumables for use by laboratorians in developing qualitative and quantitative Laboratory Developed Tests (LDTs) for use with the NeuMoDx™ Molecular Systems to detect and amplify DNA and RNA targets.

OUR INSTRUMENTS

NeuMoDx™ Molecular Systems are a family of scalable platforms that fully integrate the entire molecular diagnostic process from “sample to result.” NeuMoDx™ 288 and NeuMoDx™ 96 Molecular Systems are fully automated, continuous random-access analyzers that utilize our proprietary NeuDry™ reagent technology, which integrates magnetic particle affinity capture and real time Polymerase Chain Reaction (PCR) chemistry in a multi sample microfluidic cartridge.

NeuMoDx™ 96 Molecular System

NeuMoDx 96 Molecular System

The NeuMoDx™ 96 Molecular System is designed for the automated extraction and isolation of nucleic acids, as well as the automated amplification and detection of target nucleic acid sequences by fluorescence-based PCR.
The NeuMoDx™ 96 Molecular System consists of the instrument with touchscreen computer, accessories, and reagents and consumables.

NEUMODXtm 288 Molecular System

NeuMoDx 288 Molecular System

The NeuMoDx™ 288 Molecular System is designed for the automated extraction and isolation of nucleic acids, as well as the automated amplification and detection of target nucleic acid sequences by fluorescence-based PCR. The NeuMoDx™ 288 Molecular System consists of the instrument with touchscreen computer, accessories, and reagents and consumables.

LDT SUPPLEMENT

NeuMoDx™ Molecular Systems are versatile; in addition to IVD tests, our system can also be used as an open system to process Laboratory Developed Tests (LDTs) that have been created and validated by your lab.

CALL US TO LEARN MORE
FOR OUR CUSTOMERS

Create a scalable family of molecular testing platforms easily integrated into the molecular diagnostic process. Enable laboratory professionals to operate more efficiently and cost-effectively, thereby increasing the use of molecular diagnostic testing by medical providers to better identify and treat disease early.

Talk To Us

IMPORTANT ANNOUNCEMENT

We are excited to announce that QIAGEN has acquired all shares of NeuMoDx Molecular, Inc. The addition of NeuMoDx’s medium- and high-throughput molecular systems further expands QIAGEN’s portfolio of molecular diagnostics instruments, bolstering our leadership in automated molecular testing. We are proud to welcome NeuMoDx to our family of PCR solutions that make improvements in life possible.

To learn more, click here.